complications of retroperitoneal exploration
TRANSCRIPT
Complications of Retroperitoneal Exploration
Aram N. Demirjian, M.D.1 and Nita Ahuja, M.D.1
1Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, USA
Address correspondence and reprint requests to:
Nita Ahuja, M.D.
Associate Professor of Surgery
The Johns Hopkins Hospital
1650 Orleans Street, CRB I 342
Baltimore, MD 21231
Telephone: (410) 502-8200
Fax: (410) 502-1958
E-mail: [email protected]
Introduction and Anatomy
Surgical complications which arise secondary to exploration of the retroperitoneum are a direct
function of the structures within and their relationship to each other1. Therefore, any discussion
of the potential pitfalls and hazards of operating in the retroperitoneal space must begin with a
thorough review of the anatomy of this region, as well as the various forms of pathology which
arise there. The retroperitoneal space can be divided into three zones: the anterior pararenal
space (APS) which stretches across the midline, two perirenal spaces (one on each side of the
midline), and likewise two posterior pararenal spaces (PPS)2. The APS includes the pancreas,
retroperitoneal portions of the duodenum (2nd, 3rd, 4th), ascending and descending colon, the aorta
and vena cava, lymph nodes (para-aortic, paracaval, aortocaval), lymphatic vessels and fat. The
perirenal spaces contain the kidneys, renal hilar structures, adrenal glands, ureters, lymph nodes,
and fat. Fat is the major component of the PRS. As can be seen in Figure 11, the aforementioned
structures are in close apposition to one another. Any type of pathology arising in these areas
can quickly impinge on neighboring structures, and make surgical manipulation difficult and
possibly dangerous.
Given the diverse array of tissue types – solid organs, blood vessels, lymphatics, fat, nerves,
areolar tissue – a multitude of varying types of pathology is possible. Solid organ tumors such as
pancreatic cancers or renal cell carcinomas, sarcomas, hematoma, blood vessel injury or bowel
injury as a result of trauma, and lymph node involvement secondary to multiple different primary
malignancies can all be impetuses to explore the retroperitoneal space. The goal of this chapter
will be to describe the common complications of retroperitoneal exploration.
Complications can be separated into short-term or acute complications, and long-term or delayed
complications. The occurrence or frequency of adverse events is partly dependent on the type of
surgery being performed, the urgency of that procedure, as well as the surgical approach being
employed. We will consider some of the more common surgical reasons to explore the
retroperitoneal space and consider the attendant complications.
Pancreatic Resection
Pancreatic resections include pancreaticoduodenectomy (PD), distal pancreatectomy (DP), total
pancreatectomy (TP), as well as pancreatic drainage procedures. Given the location of the
pancreas and its intimate association with major vascular structures, bleeding from injury to the
portal vein, superior mesenteric vein or artery, the hepatic artery, the gastroduodenal artery can
easily occur. Various series estimate the risk of bleeding following pancreatic resection to
complicate 5 to 12% of cases3-5. According to one large study from Germany, bleeding
following pancreatic resection of any type occurred with a frequency of 5.7%, and led to the
death of 16% of those patients6. Bleeding after PD can either be an early or late phenomenon.
Early bleeding, defined in the German study as occurring within the first 5 days post-operatively,
is most commonly the result of unrecognized vascular injury, an error in technique (achieving
inadequate hemostasis), or intraluminal gastrointestinal bleeding, e.g. from an anastomotic suture
line. Treatment in this situation may include endoscopy, angiography, reoperation, or some
combination of those modalities. Delayed bleeding can be a devastating complication of
pancreatic surgery. Although the mortality rate for all episodes of post-pancreatectomy bleeding
was 16%, this rose to 47% if the analysis was confined to just the late bleeding. Late bleeding is
defined as occurring after post-operative day 5, and is nearly always associated with a pancreatic
fistula. Most experienced authors advocate an angiographic approach in this setting, however
the chance of requiring reoperation is high.
Another well described complication of retroperitoneal exploration is a chyle leak. This
complication is not specific to surgery of the pancreas, and could be described in any section of
this chapter, but it deserves some words of mention in terms of how it relates to pancreatic
resection. Chyle leak is a well-described phenomenon, but little data existed on the subject as is
relates to pancreatic surgery until a large series from the Johns Hopkins Hospital was reported in
20087. Results collected from more than 3500 pancreatic resections demonstrated an overall
incidence of 1.3%, with the majority of patients having a contained leak as opposed to diffuse
chylous ascites, at a ratio of approximately 2.5:1. Based upon this study, two factors were
identified as significantly enhancing the risk of developing a chyle leak: more extensive lymph
node dissection/harvest as well as a need for vascular resection. The majority of patients were
successfully treated using conservative measures such as total parenteral nutrition (TPN) and
being kept nothing per os (NPO). As could be expected, this management technique was less
often possible in the setting of diffuse chylous ascites, where reintervention was frequently
necessary.
This brings us to the most common complication associated with pancreatic resection, which is a
pancreatic leak or fistula. There is a very wide and disparate range of incidence reported for
pancreatic leak/fistula depending both upon the type of operation (PD vs. DP) and the reported
series. For PD, the rate can range from 5 to 15%, whereas for DP, some papers note the rate to
be as high as 34% (5% again being the bottom of the range)8-14. This complication cannot be
thought of as an all or none entity – there is a wide spectrum of severity which can lead to
different clinical scenarios requiring varying types and levels of intervention. This can range
from minimal interventions such as keeping the patient NPO with total parenteral nutrition
(TPN), to maximal control of the leak using further percutaneously placed drains, to reoperation
for leak control or possibly completion pancreatectomy in the most severe cases (especially
when bleeding is involved). Abscesses can also complicate the post-operative course following
pancreatic resection. This complication is said to occur in 4% to 16% of cases8. A recent
retrospective review of 908 patients from Memorial Sloan Kettering Cancer Center (MSKCC) in
New York revealed 42 “clinically significant” abscesses not otherwise associable with a
pancreatic leak or fistula15. As with pancreatic leaks, such complications range widely in
severity, and may be managed with intravenous antibiotics alone, might require drainage via
radiologically-guided percutaneous catheters, or possibly necessitate operative intervention for
control of more severe infections/intra-abdominal sepsis.
Though operative mortality associated with pancreatic resection has been reduced to below 5%
at most high-volume academic centers in North America, significant morbidity remains a
challenging problem. In an effort to better and more uniformly discuss these complications and
their effects, some groups with large pancreatic surgery experiences have applied a grading
system previously developed by Clavien et al in 1992 (Table)16. This was done by the MSKCC
group to look specifically at pancreatic leaks, fistulae, and abscesses, and they deemed
“clinically significant” to be those complications grade 2 and higher15. As previously mentioned,
this was a review of over 900 patients, and the assessment yielded 158 grade 2 or higher
complications. This group of patients required significant rates of repeat or additional
percutaneous drainage, reoperation, intensive care unit (ICU) need, and extended, complex post-
hospital care, all at significantly greater expense15.
Retroperitoneal Sarcoma Resection
The variety of structures in the retroperitoneum can give rise to a number of different types of
sarcoma. Of all the soft tissue sarcomas, the number originating in the retroperitoneum is
relatively small – only around 15% in the United States17. Symptoms are typically vague and
often appear only after tumors reach a significant size18. The most common types of
retroperitoneal sarcomas are liposarcomas and leiomyosarcomas18. Post-operative complications
following resection of a retroperitoneal sarcoma are dependent on the tumor location and the
extensive nature of the required operation, specifically referring to multi-organ resection. In
order to perform a safe and oncologically sound operation, it may be necessary to undertake
bowel resection, solid organ resection/removal, or vascular resection/reconstruction. In that
setting, any complication associated with a specific procedure or organ is added to the risk of
inadvertent injury to any other structure of the retroperitoneal space. Those complications which
have been noted by larger series, and are specific to the retroperitoneal space include bleeding,
infection/sepsis, anastomotic leak following bowel resection, pancreatic leak (with concomitant
pancreatic resection), lymphatic complications, and motor nerve injury18, 19. The exact rate of
complication associated with resection of retroperitoneal sarcoma is difficult to quantify owing
to the variability inherent to tumors of different sizes and different degrees (if any) of
multivisceral involvement. One study of 65 patients included 5% bleeding, 1 anastomotic leak
(out of 25 performed), 5% “other”, and no infections18. Another larger series (500 patients)
reported a 30-day mortality of 4% with bleeding and widespread infection as the most likely
causes of death when considering factors specific to the retroperitoneal space19. A retrospective
review of 200 primary retroperitoneal sarcomas from the United Kingdom (UK) revealed the
need to resect adjacent intra-abdominal or retroperitoneal organs 63% of the time. Significant
bleeding was the leading cause of morbidity both intra-operatively and post-operatively, and
post-surgical complications necessitated a return to the operating room in 12% of cases20.
The most commonly injured nerve in this situation includes the femoral nerve which can be
involved in or intimately associated with larger retroperitoneal lesions, and damage to which can
cause severe morbidity interfering with ambulation. This nerve can often be exceedingly
difficult to identify, especially in the setting of a bulky lesion. In fact, one group reported the use
of electromyographic (EMG) monitoring to identify the location and track the course of the
femoral nerve as a way to better preserve it21.
Another far less common complication which has been reported in select cases is that of a
duodenocaval fistula. This is a dreaded complication and has a mortality rate of nearly 40%. It
can occur after resection of a retroperitoneal tumor, most often when adjuvant radiation therapy
is employed. Patients present with either sepsis or massive gastrointestinal bleeding in a
majority of cases, and with both symptoms nearly 50% of the time22.
Adrenalectomy
This operation could be included in the following section of the chapter on urologic procedures
based upon the organ’s anatomic location, however owing to its vastly different physiologic
function, it is discussed here separately. Except for larger tumors, adrenalectomy is now
typically performed laparoscopically. The range of complications is very similar to those for
nephrectomy. These include vascular injury, bowel injury, injuries to adjacent organs (liver,
spleen, etc.), pancreatic injury, and diaphragmatic injury23. Vascular injuries are the most likely,
with the adrenal veins being most at-risk, and can complicate as many as 5% of cases24. Injuries
to the bowel and spleen are rare, with bowel injury occurring approximately 1% of the time, and
splenic injury in up to 2.5% of cases23. Diaphragm/pleural injuries are uncommon, but can
present a challenging situation. Given the anatomic location of the adrenal gland (kidney as
well), the posterior portion of the diaphragm can be at risk. Injury in this location can happen
during both open and minimally invasive procedures, though it is typically readily identified
intra-operatively in the open setting. Laparoscopy can provide the confounders of more limited
visualization, along with high intra-abdominal pressure and the possibility of forced insufflating
gas into the thoracic space23. Both surgeon and anesthesiologist must be aware and vigilant in
order to prevent serious consequences. Fortunately, this injury occurs in less than 1% of adrenal
and renal resections23.
Urologic Procedures
Much of the information available regarding complications of retroperitoneal surgery comes
from the urologic literature. In this section, we will consider two procedures whose study has
contributed significantly to the understanding of the dangers of working in a tight anatomical
space.
Nephrectomy
There are multiple factors to consider when discussing renal surgery. These primarily include
the approach (laparoscopic vs. open) and the operation (radical vs. partial nephrectomy).
Laparoscopic radical nephrectomy (LRN) has many applications and has become the standard
for early-stage renal carcinomas. Inadvertent injury to adjacent organs and damage to vascular
structures are the two most frequent categories comprising morbidity associated with this
procedure. Based upon a recent meta-analysis, these occur with frequencies of 4% and 2%,
respectively. Organs most commonly at risk include small or large bowel, the spleen, the
pancreas, and the diaphragm. Bowel injury occurs infrequently, 0.75 to 0.8%, but can be a
devastating complication as it is often unrecognized at the time of surgery, and may present
multiple days into the post-operative course25, 26. Splenic injury has a reported incidence of 1.4%,
and pancreatic injury occurs 0.4% to 2.1% of the time, all during left nephrectomy27, 28. Vascular
injuries typically stem from failure to control the vessels of the renal hilum. Chylous ascites can
also be a complication of LRN, but this is uncommon. Factors which have been found to
contribute to these complications are believed to include surgeon experience, patient obesity,
tumor size/stage, and prior abdominal operations27. Studies have shown no significant
differences in the rate of complications when comparing laparoscopic and open procedures.
When considering partial nephrectomy, the same risks apply as those with LRN, with the added
possibilities of bleeding from the renal parenchyma and urine leak. Urine leak appears to occur
in less than 3% of cases29, 30.
Another uncommon complication of retroperitoneal surgery, though not exclusive to
nephrectomy, is an acquired lumbar hernia. It is most appropriately discussed in this section of
the chapter as it (the incisional type) was first described in the context of that operation in the
early 1950’s31. The anatomic boundaries of the region are the 12th rib (superior), the erector
spinae muscles (medial), the external oblique (lateral), and the iliac crest (inferior)32. With
regard to exploration of the retroperitoneal space, lumbar hernia would most commonly occur as
a consequence of nephrectomy, abdominal aortic aneurysm (AAA) repair via a retroperitoneal
approach, and possibly a retroperitoneal sarcoma resection. Diagnosis may be difficult, owing
mainly to the location of the lumbar triangle, and the hernia can have a multitude of
presentations ranging from no symptoms at all, to pain, to bowel or urinary obstructions. As
lumbar hernias tend to steadily increase in size, most advocate relatively early surgical repair in
order to avoid further complications32.
An extremely rare, but reported complication of laparoscopic nephrectomy is injury to the
common bile duct (CBD). A recent case report described this incident as occurring during a
laparoscopic partial nephrectomy, in the setting of multiple adhesions (due to prior
cholecystectomy) causing bowel to be adherent to the underside of the liver. The injury was
recognized at the time of operation and repaired primarily33. The rarity of this complication is
underscored by the fact that is goes unmentioned in the exhaustive report by Permpongkosol et
al. of complications of laparoscopic urologic surgery34.
Retroperitoneal Lymph Node Dissection
A bulk of the information regarding complications of retroperitoneal surgery is derived from the
study of retroperitoneal lymph node dissection (RPLND), particularly when done for testicular
cancer. This was typically done as an open procedure, but more recently has evolved to
frequently include the laparoscopic approach, which was first introduced in the early 1990’s35.
As in all cases, complications can be classified into two groups: intraoperative and postoperative,
and in this case, one must also consider whether the procedure was performed after
chemotherapy was given. Potential intraoperative complications of laparoscopic RPLND
(LRPLND) include vascular injury, bowel injury, and solid organ injury. Possible postoperative
complications are retrograde ejaculation, chylous ascites, lymphocele, retroperitoneal hematoma,
and nerve injury36. Vascular complications are the most common and occur with a frequency of
2.2% to 20% depending on the series. Additionally, vascular damage is the primary reason
necessitating the conversion to an open procedure. Vessels reported to be most likely involved
include the vena cava, branches of the aorta, renal vessels, lumbar veins gonadal veins36.
Conclusion
Morbidity associated with surgical exploration of the retroperitoneal space is closely tied to how
densely packed this area is. Complications are a function of the different operations performed
in that space, but in all cases, more so than in other areas, adjacent organs are involved or at-risk
One must anticipate the need for multivisceral complications – both planned and unplanned –
and careful counseling of the patient is needed to discuss potential complications and the
potentially unpredictable and various nature of those complications. Given the wide range of
possible complications, it stands to reason that high-volume surgeons, with a wealth of
experience in the retroperitoneal space, will likely have lower operative risk.
References
1. Mirilas P, Skandalakis JE. Surgical anatomy of the retroperitoneal spaces, Part V: Surgical applications and complications. Am Surg 2010;76:358-64.
2. Vesselle HJ, Miraldi FD. FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. Radiographics 1998;18:805-23; discussion 23-4.
3. Sato N, Yamaguchi K, Shimizu S, et al. Coil embolization of bleeding visceral pseudoaneurysms following pancreatectomy: the importance of early angiography. Arch Surg 1998;133:1099-102.
4. Balladur P, Christophe M, Tiret E, Parc R. Bleeding of the pancreatic stump following pancreatoduodenectomy for cancer. Hepatogastroenterology 1996;43:268-70.
5. Halloran CM, Ghaneh P, Bosonnet L, Hartley MN, Sutton R, Neoptolemos JP. Complications of pancreatic cancer resection. Dig Surg 2002;19:138-46.
6. Yekebas EF, Wolfram L, Cataldegirmen G, et al. Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections. Ann Surg 2007;246:269-80.
7. Assumpcao L, Cameron JL, Wolfgang CL, et al. Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience. J Gastrointest Surg 2008;12:1915-23.
8. DeOliveira ML, Winter JM, Schafer M, et al. Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 2006;244:931-7; discussion 7-9.
9. Balcom JHt, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 2001;136:391-8.
10. Kazanjian KK, Hines OJ, Eibl G, Reber HA. Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch Surg 2005;140:849-54; discussion 54-6.
11. Aranha GV, Aaron JM, Shoup M, Pickleman J. Current management of pancreatic fistula after pancreaticoduodenectomy. Surgery 2006;140:561-8; discussion 8-9.
12. Balzano G, Zerbi A, Cristallo M, Di Carlo V. The unsolved problem of fistula after left pancreatectomy: the benefit of cautious drain management. J Gastrointest Surg 2005;9:837-42.
13. Rodriguez JR, Germes SS, Pandharipande PV, et al. Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg 2006;141:361-5; discussion 6.
14. Lillemoe KD, Kaushal S, Cameron JL, Sohn TA, Pitt HA, Yeo CJ. Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg 1999;229:693-8; discussion 8-700.
15. Vin Y, Sima CS, Getrajdman GI, et al. Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg 2008;207:490-8.
16. Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992;111:518-26.
17. Hueman MT, Herman JM, Ahuja N. Management of retroperitoneal sarcomas. Surg Clin North Am 2008;88:583-97, vii.
18. Sogaard AS, Laurberg JM, Sorensen M, et al. Intraabdominal and retroperitoneal soft-tissue sarcomas--outcome of surgical treatment in primary and recurrent tumors. World J Surg Oncol 2010;8:81.
19. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998;228:355-65.
20. Strauss DC, Hayes AJ, Thway K, Moskovic EC, Fisher C, Thomas JM. Surgical management of primary retroperitoneal sarcoma. Br J Surg 2010;97:698-706.
21. Guo L, Clark JP, 3rd, Warren RS, Nakakura EK. Compound muscle action potentials and spontaneous electromyography can be used to identify and protect the femoral nerve during resection of large retroperitoneal tumors. Ann Surg Oncol 2008;15:1594-9.
22. Moran EA, Porterfield JR, Jr., Nagorney DM. Duodenocaval fistula after irradiation and resection of a retroperitoneal sarcoma. J Gastrointest Surg 2008;12:776-8.
23. Strebel RT, Muntener M, Sulser T. Intraoperative complications of laparoscopic adrenalectomy. World J Urol 2008;26:555-60.
24. Walz MK, Alesina PF, Wenger FA, et al. Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. Surgery 2006;140:943-8; discussion 8-50.
25. Bishoff JT, Allaf ME, Kirkels W, Moore RG, Kavoussi LR, Schroder F. Laparoscopic bowel injury: incidence and clinical presentation. J Urol 1999;161:887-90.
26. Schwartz MJ, Faiena I, Cinman N, et al. Laparoscopic bowel injury in retroperitoneal surgery: current incidence and outcomes. J Urol 2010;184:589-94.
27. Breda A, Finelli A, Janetschek G, Porpiglia F, Montorsi F. Complications of laparoscopic surgery for renal masses: prevention, management, and comparison with the open experience. Eur Urol 2009;55:836-50.
28. Varkarakis IM, Allaf ME, Bhayani SB, et al. Pancreatic injuries during laparoscopic urologic surgery. Urology 2004;64:1089-93.
29. Simmons MN, Gill IS. Decreased complications of contemporary laparoscopic partial nephrectomy: use of a standardized reporting system. J Urol 2007;177:2067-73; discussion 73.
30. Turna B, Frota R, Kamoi K, et al. Risk factor analysis of postoperative complications in laparoscopic partial nephrectomy. J Urol 2008;179:1289-94; discussion 94-5.
31. Kretchmer HL. Hernia of the kidney. J Urol 1951;65:944-9.
32. Moreno-Egea A, Baena EG, Calle MC, Martinez JA, Albasini JL. Controversies in the current management of lumbar hernias. Arch Surg 2007;142:82-8.
33. Canes D, Aron M, Nguyen MM, Winans C, Chand B, Gill IS. Common bile duct injury during urologic laparoscopy. J Endourol 2008;22:1483-4.
34. Permpongkosol S, Link RE, Su LM, et al. Complications of 2,775 urological laparoscopic procedures: 1993 to 2005. J Urol 2007;177:580-5.
35. Rukstalis DB, Chodak GW. Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma. J Urol 1992;148:1907-9; discussion 9-10.
36. Kenney PA, Tuerk IA. Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancer. World J Urol 2008;26:561-9.
Figure 11